Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.

Homma S, Thompson JL, Qian M, Ye S, Di Tullio MR, Lip GY, Mann DL, Sacco RL, Levin B, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Mohr JP, Labovitz AJ, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD; WARCEF Investigators..

Circ Heart Fail. 2015 May;8(3):504-9. doi: 10.1161/CIRCHEARTFAILURE.114.001725. Epub 2015 Apr 7.

2.

Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.

Graham S, Ye S, Qian M, Sanford AR, Di Tullio MR, Sacco RL, Mann DL, Levin B, Pullicino PM, Freudenberger RS, Teerlink JR, Mohr JP, Labovitz AJ, Lip GY, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Thompson JL, Homma S; WARCEF Investigators..

PLoS One. 2014 Nov 26;9(11):e113447. doi: 10.1371/journal.pone.0113447. eCollection 2014 Nov 26.

3.

Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.

Pullicino PM, Qian M, Sacco RL, Freudenberger R, Graham S, Teerlink JR, Mann D, Di Tullio MR, Ponikowski P, Lok DJ, Anker SD, Lip GY, Estol CJ, Levin B, Mohr JP, Thompson JL, Homma S; WARCEF Investigators..

Cerebrovasc Dis. 2014;38(3):176-81. doi: 10.1159/000365502. Epub 2014 Oct 9.

4.

Warfarin and aspirin in patients with heart failure and sinus rhythm.

Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R; WARCEF Investigators..

N Engl J Med. 2012 May 17;366(20):1859-69. doi: 10.1056/NEJMoa1202299. Epub 2012 May 2.

5.

CsrA modulates levels of lipoproteins and key regulators of gene expression critical for pathogenic mechanisms of Borrelia burgdorferi.

Karna SL, Sanjuan E, Esteve-Gassent MD, Miller CL, Maruskova M, Seshu J.

Infect Immun. 2011 Feb;79(2):732-44. doi: 10.1128/IAI.00882-10. Epub 2010 Nov 15.

6.

Heart failure with preserved ejection fraction in outpatients with unexplained dyspnea: a pressure-volume loop analysis.

Penicka M, Bartunek J, Trakalova H, Hrabakova H, Maruskova M, Karasek J, Kocka V.

J Am Coll Cardiol. 2010 Apr 20;55(16):1701-10. doi: 10.1016/j.jacc.2009.11.076.

7.

Overexpression of CsrA (BB0184) alters the morphology and antigen profiles of Borrelia burgdorferi.

Sanjuan E, Esteve-Gassent MD, Maruskova M, Seshu J.

Infect Immun. 2009 Nov;77(11):5149-62. doi: 10.1128/IAI.00673-09. Epub 2009 Sep 8.

8.

Myocardial viability and cardiac dyssynchrony as strong predictors of perioperative mortality in high-risk patients with ischemic cardiomyopathy having coronary artery bypass surgery.

Maruskova M, Gregor P, Bartunek J, Tintera J, Penicka M.

J Thorac Cardiovasc Surg. 2009 Jul;138(1):62-8. doi: 10.1016/j.jtcvs.2008.11.040. Epub 2009 Feb 7.

9.

Deletion of BBA64, BBA65, and BBA66 loci does not alter the infectivity of Borrelia burgdorferi in the murine model of Lyme disease.

Maruskova M, Seshu J.

Infect Immun. 2008 Nov;76(11):5274-84. doi: 10.1128/IAI.00803-08. Epub 2008 Sep 2.

10.

Role of the BBA64 locus of Borrelia burgdorferi in early stages of infectivity in a murine model of Lyme disease.

Maruskova M, Esteve-Gassent MD, Sexton VL, Seshu J.

Infect Immun. 2008 Jan;76(1):391-402. Epub 2007 Nov 5.

11.

Severe left ventricular dyssynchrony is associated with poor prognosis in patients with moderate systolic heart failure undergoing coronary artery bypass grafting.

Penicka M, Bartunek J, Lang O, Medilek K, Tousek P, Vanderheyden M, De Bruyne B, Maruskova M, Widimsky P.

J Am Coll Cardiol. 2007 Oct 2;50(14):1315-23. Epub 2007 Sep 17.

Supplemental Content

Loading ...
Support Center